IOVANCE BIOTHERAPEUTICS INC COM USD0.000041666 earnings per share and revenue

0JDK earnings per share for the last quarter are -0.28 USD whereas the estimation was -0.30 USD which accounts for 6.31% surprise. Company revenue for the same period amounts to 58.55 M USD despite the estimated figure of 53.79 M USD. Estimated earnings per share for the next quarter are -0.26 USD, and revenue is expected to reach 71.51 M USD. Also watch annual changes over time to get a bigger picture of 0JDK earnings per share and revenue dynamics.